Analysis of factors influencing aspiration risk following chemoradiation for oropharyngeal cancer

被引:29
|
作者
Nguyen, N. P. [1 ]
Frank, C. [2 ]
Moltz, C. C. [2 ]
Vos, P. [3 ]
Smith, H. J. [4 ]
Nguyen, P. D. [5 ]
Martinez, T. [5 ]
Karlsson, U. [6 ]
Dutta, S. [7 ]
Lemanski, C. [8 ]
Nguyen, L. M. [9 ]
Sallah, S. [10 ]
机构
[1] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85724 USA
[2] VA N Texas Hlth Care Syst, Dept Speech Pathol, Dallas, TX USA
[3] E Carolina Univ, Dept Biostat, Greenville, NC USA
[4] VA N Texas Hlth Care Syst, Dept Radiol, Dallas, TX USA
[5] VA N Texas Hlth Care Syst, Dept Radiat Oncol, Dallas, TX USA
[6] E Carolina Univ, Dept Radiat Oncol, Greenville, NC USA
[7] Univ So Calif, Dept Radiat Oncol, Los Angeles, CA USA
[8] Ctr Val Aurelle, Dept Radiat Oncol, Montpellier, France
[9] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[10] Novo Nordisk AS, Div Hematol Res, Athens, Greece
关键词
MODIFIED BARIUM SWALLOW; NECK-CANCER; RADIATION-THERAPY; ADVANCED HEAD; DYSPHAGIA; CARCINOMA; TERM; REHABILITATION; CHEMOTHERAPY; HYDROXYUREA;
D O I
10.1259/bjr/72852974
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Our aim was to identify risk factors for aspiration following concurrent chemoradiation for oropharyngeal cancer. 46 patients with locally advanced oropharyngeal carcinoma underwent concurrent chemoradiation at our institution. All patients underwent modified barium swallow to assess dysphagia severity and to determine the need for continued tube feedings after treatment. Dysphagia severity was graded as 1-7. There were 5 Grade 2, 11 Grade 3, 5 Grade 4, 5 Grade 5, 10 Grade 6 and 10 Grade 7 scores. 25 patients (54%) developed aspiration (5 trace, 20 severe). The aspiration rate for T1-T2 and T3-T4 tumours was 31% and 67%, respectively (p=0.03). There was no statistical difference in the aspiration rate between the base of the tongue and tonsillar carcinoma (p=0.23). Despite anatomical organ preservation, most patients with locally advanced oropharyngeal carcinoma had moderate to severe dysphagia after chemoradiation. Patients with large tumours had a significant risk of developing aspiration following treatment.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 50 条
  • [31] Surgically treated oropharyngeal cancer: risk factors and tumor characteristics
    Baumeister, Philipp
    Reiter, Maximilian
    Welz, Christian
    Becker, Sven
    Betz, Christian
    Harreus, Ulrich
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (06) : 1011 - 1019
  • [32] Risk factors for brain metastases after definitive chemoradiation for locally advanced non-small cell lung cancer
    Petrovic, Marina
    Tomic, Ilija
    Jovanovic, Dragana
    VOJNOSANITETSKI PREGLED, 2009, 66 (11) : 876 - 880
  • [33] Risk Factors for Percutaneous Endoscopic Gastrostomy Tube Placement During Chemoradiotherapy for Oropharyngeal Cancer
    Strom, Tobin
    Trotti, Andy M.
    Kish, Julie
    Rao, Nikhil G.
    McCaffrey, Judith
    Padhya, Tapan A.
    Lin, Hui-Yi
    Fulp, William
    Caudell, Jimmy J.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 139 (11) : 1242 - 1246
  • [34] Risk factors of pneumonitis following chemoradiotherapy for lung cancer
    Yamada, M
    Kudoh, S
    Hirata, K
    Nakajima, T
    Yoshikawa, J
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (01) : 71 - 75
  • [35] Prognostic factors in oropharyngeal cancer - analysis of 627 cases receiving definitive radiotherapy
    Agarwal, Jai Prakash
    Mallick, Indranil
    Bhutani, Ritu
    Ghosh-Laskar, Sarbani
    Gupta, Tejpal
    Budrukkar, Ashwini
    Murthy, Vedang
    Sengar, Manju
    Dinshaw, Ketayun A.
    ACTA ONCOLOGICA, 2009, 48 (07) : 1026 - 1033
  • [36] Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial
    Hegde, John V.
    Shaverdian, Narek
    Felix, Carol
    Wang, Pin-Chieh
    Veruttipong, Darlene
    Hsu, Sophia
    Riess, Jonathan W.
    Rao, Shyam D.
    Daly, Megan E.
    Chen, Allen M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (03): : 647 - 651
  • [37] Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study
    Kawai, Sadayuki
    Yokota, Tomoya
    Onozawa, Yusuke
    Hamauchi, Satoshi
    Fukutomi, Akira
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Onitsuka, Tetsuro
    Yurikusa, Takashi
    Todaka, Akiko
    Tsushima, Takahiro
    Yoshida, Yukio
    Kito, Yosuke
    Mori, Keita
    Yasui, Hirofumi
    BMC CANCER, 2017, 17
  • [38] Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma
    Barney, Christian L.
    Walston, Steve
    Zamora, Pedro
    Healy, Erin H.
    Nolan, Nicole
    Diavolitsis, Virginia M.
    Neki, Anterpreet
    Rupert, Robert
    Savvides, Panos
    Agrawal, Amit
    Old, Matthew
    Ozer, Enver
    Carrau, Ricardo
    Kang, Stephen
    Rocco, James
    Teknos, Theodoros
    Grecula, John C.
    Wobb, Jessica
    Mitchell, Darrion
    Blakaj, Dukagjin
    Bhatt, Aashish D.
    ORAL ONCOLOGY, 2018, 79 : 9 - 14
  • [39] Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer
    Alfieri, Salvatore
    Ripamonti, Carla I.
    Marceglia, Sara
    Orlandi, Ester
    Iacovelli, Nicola A.
    Granata, Roberta
    Cavallo, Anna
    Pozzi, Paolo
    Boffi, Roberto
    Bergamini, Cristiana
    Imbimbo, Martina
    Pala, Laura
    Resteghini, Carlo
    Mirabile, Aurora
    Locati, Laura D.
    Licitra, Lisa
    Bossi, Paolo
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1521 - E1527
  • [40] Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal Cancer
    Meade, S.
    Gaunt, P.
    Hartley, A.
    Robinson, M.
    Harrop, V.
    Cashmore, J.
    Wagstaff, L.
    Babrah, J.
    Bowden, S. J.
    Mehanna, H.
    Sanghera, P.
    CLINICAL ONCOLOGY, 2018, 30 (06) : 366 - 374